Biblio

Export 2696 results:
Author Keyword Title Type [ Year(Asc)]
2021
T. Tian, Qin, X., Wang, Y., Shi, Y., and Yang, X., “40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.”, J Alzheimers Dis, vol. 84, no. 3, pp. 983-993, 2021.
N. L. Spartano, Himali, J. J., Trinquart, L., Yang, Q., Weinstein, G., Satizabal, C. L., Dukes, K. A., Beiser, A. S., Murabito, J. M., Vasan, R. S., and Seshadri, S., “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, 2021.
R. B. Alam, Singleton, C. R., Aguiñaga, S., Chodzko-Zajko, W., Jahan, N. A., Oke, A., and Schwingel, A., “Is Acculturation Associated with the Cognitive Performance of Older Hispanics?”, J Alzheimers Dis, 2021.
I. Ben Ayed, Castor-Guyonvarch, N., Amimour, S., Naija, S., Aouichaoui, C., Ben Omor, S., Tabka, Z., and Massioui, F. El, “Acute Exercise and Cognitive Function in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 2, pp. 749-760, 2021.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., “Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
L. M. Walden, Hu, S., Madabhushi, A., and Prescott, J. W., “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
M. Basta, Zaganas, I., Simos, P., Koutentaki, E., Dimovasili, C., Mathioudakis, L., Bourbouli, M., Panagiotakis, S., Kapetanaki, S., and Vgontzas, A., “Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.”, J Alzheimers Dis, vol. 79, no. 2, pp. 763-771, 2021.
R. J. Piers, Liu, Y., Ang, T. F. A., Tao, Q., Au, R., and Qiu, W. Qiao, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1269-1279, 2021.
M. E. Nelson, Andel, R., Nedelska, Z., Martinkova, J., Cechova, K., Marková, H., Matuskova, V., Nikolai, T., Lerch, O., Pařízková, M., Laczó, J., Vyhnálek, M., and Hort, J., “The Association Between Homocysteine and Memory in Older Adults.”, J Alzheimers Dis, vol. 81, no. 1, pp. 413-426, 2021.
D. Ren, Lopez, O. L., Lingler, J. H., and Conley, Y., “Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.”, J Alzheimers Dis, vol. 81, no. 3, pp. 943-948, 2021.
A. Kapasi, Yu, L., Stewart, C., Schneider, J. A., Bennett, D. A., and Boyle, P. A., “Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility.”, J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
M. Babić Leko, Jurasović, J., Perković, M. Nikolac, Španić, E., Sekovanić, A., Orct, T., Škudar, V. Lukinović, Baronica, K. Bačić, Kiđemet-Piskač, S., Vogrinc, Ž., Pivac, N., Borovečki, F., Hof, P. R., and Šimić, G., “The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 2, pp. 661-672, 2021.
M. Germán Borda, Copete, A. María Aya, Tovar-Rios, D. Alejandro, Jaramillo-Jimenez, A., Giil, L. Melvær, Soennesyn, H., Gómez-Arteaga, C., Venegas-Sanabria, L. Carlos, Kristiansen, I., Chavarro-Carvajal, D. Andrés, Caicedo, S., Cano-Gutierrez, C. Alberto, Vik-Mo, A., and Aarsland, D., “Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
M. M. Gonzales, Samra, J., O'Donnell, A., R Mackin, S., Salinas, J., Jacob, M., Satizabal, C. L., Aparicio, H. J., Thibault, E. G., Sanchez, J. S., Finney, R., Rubinstein, Z. B., Mayblyum, D. V., Killiany, R. J., Decarli, C. S., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”, J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
K. Hirao, Yamashita, F., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Kanetaka, H., Umahara, T., Sakurai, H., Hanyu, H., and Shimizu, S., “Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 2, pp. 877-883, 2021.
H. Jakubowski, Zioła-Frankowska, A., Frankowski, M., Perła-Kaján, J., Refsum, H., de Jager, C. A., and A Smith, D., “B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
W. Hendricus Quint, Matečko-Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. Marcus, and Vogels, T., “Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.”, J Alzheimers Dis, vol. 80, no. 2, pp. 813-829, 2021.
L. Smith, Shin, J. Il, Oh, H., Carmichael, C., Jacob, L., Stefanac, S., Lindsay, R. K., Soysal, P., Veronese, N., Tully, M. A., Butler, L., Barnett, Y., and Koyanagi, A., “Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries.”, J Alzheimers Dis, 2021.
A. G. Senejani, Maghsoudlou, J., El-Zohiry, D., Gaur, G., Wawrzeniak, K., Caravaglia, C., Khatri, V. A., MacDonald, A., and Sapi, E., “Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.”, J Alzheimers Dis, 2021.
A. M. Stickel, Tarraf, W., Gonzalez, K. A., Isasi, C. R., Kaplan, R., Gallo, L. C., Zeng, D., Cai, J., Pirzada, A., Daviglus, M. L., Goodman, Z. T., Schneiderman, N., and González, H. M., “Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos: Investigation of Neurocognitive Aging.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1203-1218, 2021.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M., “Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
J. Svensson, Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M., Bjerke, M., Månsson, J. - E., and Wallin, A., “Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.”, J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
P. P. Chum, Hakim, M. A., and Behringer, E. J., “Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.”, J Alzheimers Dis, 2021.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.

Pages